Our Model

Our focus

AID Genomics is a research and development-driven company focused on the development of precision medicine-based diagnostics, primarily for oncology but also for hereditary rare diseases and infectious diseases.
‍
Our focus is to detect cancer and genetic diseases at early stages and to make precision medicine affordable to patients, enabling them to enjoy longer and healthier lives. In addition, we are devoting major resources to the global effort to fight the COVID-19 pandemic and other deleterious infectious diseases.

Research and Development

Our research and development efforts are focused on the following areas:

Early cancer detection technologies and solutions

We are committed to keep optimizing the biochemistry and the bio-computational processes behind our technologies, allowing for superior detection rates and improving early clinical prediction models.

Automation solutions

In cooperation with our hardware suppliers and bio-automation partenrs, we are creating advanced software solutions for automated sample and library preparation, pooling, and data interpretation. Thus, enabling streamlined workflows and optimized connectivity between different laboratory instruments.

Next-Generation Sequencing (NGS)-based cancer therapy selection solutions

Based on clinical demand and scientific progress, we are exploring different sequencing platforms and designing different test panels to update the personal selection toolset for the constantly growing list of cancer-targeted therapies. We are continuously working on designing solutions that require low sample input, high library conversion rates, and short hands-on time. We are also continuously improving our data analysis and developing our innovative analysis pipelines.
Research and Development

Next-generation sequencing (NGS) based cancer therapy selection solutions

Based on clinical market demand and scientific progress, we are exploring different sequencing platforms and designing different panels to meet various clinical needs. We are continuously working on designing solutions that require low sample input, high library conversion rates and short hands-on time. We are also improving our data analysis and developing our analysis pipeline.

Fight against COVID-19

In February 2020, we shifted a substantial part of our resources to develop large-scale, nationwide diagnostic capabilities to help in the fight against COVID-19.

We continue to increase our depth of understanding of the disease’s biology and the utility of our testing.

Carefully Crafted

Amazing Webflow Template

Censes aut interrogari ut placet, inquam tum dicere exorsus. Sisine metu egendae praesidia firmissima filium morte multavit si sine dubio praeclara. Probabo, inquit, modo dixi, constituto, ut aliquid ex eo ortum, tam crudelis fuisse. Laudem et inter argumentum.

Buy Template
Carefully Crafted

Amazing Webflow Template

Censes aut interrogari ut placet, inquam tum dicere exorsus. Sisine metu egendae praesidia firmissima filium morte multavit si sine dubio praeclara. Probabo, inquit, modo dixi, constituto, ut aliquid ex eo ortum, tam crudelis fuisse. Laudem et inter argumentum.

Buy Template

Our laboratories

We currently operate two laboratories in Israel:

Rehovot Lab, Israel

Established in 2019, the lab has been accredited by the Israeli Ministry of Health as a clinical genetics laboratory. It currently serves as our in-house research and development laboratory.

Jerusalem Lab, Israel

Our Jerusalem lab is accredited by the Israeli Ministry of Health as one of the few private labs specializing in COVID-19 reverse transcription-polymerase chain reaction (RT-PCR) tests. It is a biosafety level (BSL) 2 lab that works with pathogens associated with human diseases and has the capacity to process up to 70,000 COVID-19 RT-PCR tests per 24-hour workday.
AID GENOMICS
lab solution
In addition to our AID Genomics laboratories, we also assisted to establish 7 additional independent, IMOH accredited laboratories across Israel.
Moreover, we established a fully functional, accredited COVID-19 lab as a turn-key solution in several locations, such as in Kazakhstan.

Navigation

Our modelProducts & ServicesCovid-19 ResponseAbout us

Resource Centre

FAQContact us
Made by Sparklord
AIDGenomics All Rights Reserved 2021